J. Paul Abernathy - 13 Aug 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Reporting relationship: Director
Issuer ticker: NHC
Reported as of: 13 Aug 2025
Net transaction value: +$100
SEC form: 4
Accepted by SEC: 15 Aug 2025, 16:29:33 UTC
Prior SEC filing: 09 May 2025
Next SEC filing: 16 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ J. Paul Abernathy

Key filing fact

J. Paul Abernathy filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 15 Aug 2025.

Key facts

This page summarizes J. Paul Abernathy's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
3 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 15 Aug 2025, 16:29.

Change

Previous filing in this sequence was filed on 09 May 2025.
Current net transaction value: +$100.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001261687 Primary reporting owner

ABERNATHY JAMES PAUL

Relationship: Director
Address: 1523 MIRABELLA WAY, MURFREESBORO
Signature: /s/ J. Paul Abernathy
Signature date: 15 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHC transaction

Shares of Common Stock

Options Exercise

Transaction value: $287,276
Shares: +4,010
Change %: +11%
Price: $71.64
Shares after: 39,033
Date: 13 Aug 2025
Ownership: Direct
Footnotes: F1

NHC transaction

Shares of Common Stock

Tax liability

Transaction value: $287,176
Shares: -2,639
Change %: -6.8%
Price: $108.82
Shares after: 36,394
Date: 13 Aug 2025
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHC transaction Derivative

Option to Purchase Common Stock [2021 Grant]

Options Exercise

Transaction value: $0
Shares: -4,010
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 13 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,010
Exercise price: $71.64
Footnotes: F1

NHC holding Derivative

Option to Purchase Common Stock [2022 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 13 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $69.19

NHC holding Derivative

Option to Purchase Common Stock [2023 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 13 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $55.75

NHC holding Derivative

Option to Purchase Common Stock [2024 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 13 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $96.03

NHC holding Derivative

Option to Purchase Common Stock [2025 Grant]

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,500
Date: 13 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,500
Exercise price: $94.66

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

Footnote F2

Shares were withheld by the Company to pay the exercise price.

Footnote F3

Total amount of shares beneficially owned following transactions reported on this form.